Clincosm LogoSign in Get a demo

Post-Essential Thrombocythemia Myelofibrosis

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

    Recruiting
    • Myelofibrosis; Anemia
    • +5 more
    • Jacksonville, Florida
    • +6 more
    Jan 3, 2023

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +148 more
    Oct 10, 2022

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Birmingham, Alabama
    • +151 more
    Aug 22, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Feb 10, 2022

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Active, not recruiting
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +166 more
    Jan 27, 2022

    Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +22 more
    Dec 7, 2021

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +121 more
    Oct 21, 2021

    A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

    Active, not recruiting
    • Primary Myelofibrosis
    • +2 more
    • Jakavi
    • Aachen, Germany
      Novartis Investigative Site
    Sep 6, 2021

    Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

    Completed
    Has Results
    • Chronic Phase Myelofibrosis
    • +3 more
    • Boston, Massachusetts
    • +2 more
    May 27, 2021

    Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Jaktinib hydrochloride tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Jun 11, 2021

    Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Farmington Hills, Michigan
    • +1 more
    Jun 5, 2021

    Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

    Withdrawn
    • Primary Myelofibrosis
    • +4 more
    • (no location specified)
    Mar 2, 2021

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    Has Results
    • Primary Myelofibrosis
    • +4 more
    • Scottsdale, Arizona
    • +21 more
    Jan 18, 2021

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in United States (PU-H71, Ruxolitinib)

    Terminated
    • Myelofibrosis
    • +3 more
    • New Haven, Connecticut
    • +9 more
    Oct 19, 2020

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +80 more
    Sep 25, 2020

    Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Vienna, Austria
    • +19 more
    Apr 28, 2020

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +113 more
    Apr 13, 2020

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Highland, California
    • +20 more
    Mar 18, 2019

    Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Canada, United States

    Completed
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +5 more
    Jan 31, 2019

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Australia,

    Completed
    • Primary Myelofibrosis
    • +2 more
    • Stanford, California
    • +5 more
    Jan 31, 2019